Desflurane

Brand Names: Suprane

Drug Class: General anesthetic, halogenated ether

Overview

Desflurane is a volatile halogenated ether general anesthetic used for induction and maintenance of anesthesia during surgery. It has low blood-gas solubility, allowing rapid induction and emergence from anesthesia.

Mechanism of Action

Potentiates GABA-A receptor activity and inhibits excitatory neurotransmission via NMDA receptor antagonism, producing dose-dependent CNS depression and anesthesia.

Indications

  • Induction and maintenance of general anesthesia in adults
  • Maintenance of general anesthesia in pediatric patients after induction with other agents

Dosage

Inhalation: Induction: 4-11% with oxygen or oxygen/nitrous oxide mixture; Maintenance: 2-6% with oxygen or oxygen/nitrous oxide mixture. Adjust based on patient response and vital signs.

Contraindications

  • Known or suspected genetic susceptibility to malignant hyperthermia
  • Patients with known sensitivity to desflurane or other halogenated agents
  • Induction of anesthesia in pediatric patients due to risk of respiratory adverse events

Side Effects

  • Hypotension
  • Nausea
  • Vomiting
  • Cough
  • Laryngospasm
  • Bronchospasm
  • Bradycardia
  • Hypertension
  • Arrhythmias
  • Malignant hyperthermia
  • Increased intracranial pressure
  • Hepatitis (rare)

Interactions

  • Non-depolarizing muscle relaxants: Potentiates neuromuscular blockade
  • Opioids: Enhances respiratory depression
  • Benzodiazepines: Enhances CNS depression
  • MAO inhibitors: May cause hypertensive crisis
  • Epinephrine: May increase risk of ventricular arrhythmias